1. New Horizons andOld Dilemmas: New AEDs and Generics Jacqueline A. French, M.D. NYU Comprehensive Epilepsy Center 2. ANTIEPILEPTIC DRUG DEVELOPMENT 1840 1860 1880 1900…
Slide 1Nuovi farmaci in asma e BPCO Bianca Beghè, Leonardo M Fabbri Corso di Formazione al Personale Nycomed Modena, 6-7/8-9 Settembre 2011 Clinica di Malattie delApparato…
Slide 1Phase II/III Design: Case Study Case study: Seamless Phase II/III Design for Registration Program Jeff Maca, Ph.D. Senior Associate Director Novartis Pharmaceuticals…
Slide 1Frank Svec, MD, PhD Clinical Professor of Medicine Tulane University School of Medicine New Orleans, Louisiana Kevan Chambers Announcer Medscape Diabetes & Endocrinology…
1.CSMUH Clinical Trial Centers Experiences on The Implementation of Clinical Trials James Cheng-Chung Wei, MD, Ph.D. Chief, Division of Allergy, Immunology and Rheumatology…
1. - DR. SRIRAM.R 2. Clonidine and Guanfacine MOA - Stimulation of alpha2-adrenergic receptors reduces the firing rate of noradrenergic neurons and of plasma concentrations…
OMALIZUMAB OMALIZUMAB Dr. RENJU S RAVI Overview Introduction Bronchial asthma – Definition, Symptoms, Classification Pathophysiology Approaches to treatment Role of IgE…